Skip to main content
TipRanks
Go Ultimate75% OFF

Alnylam Pharma (0HD2) Q4 2022 Earnings Report

4 Followers

GB:0HD2 Q4 2022 EPS Results

Actual EPS
-$1.68
Consensus EPS
-$1.86
Beat/Miss
Beat by +$0.18
One Year Ago EPS
-$2.16

GB:0HD2 Q4 2022 Revenue Results

Actual Revenue
$335.04M
Expected Revenue
$313.13M
Beat/Miss
Beat by +$21.90M
YoY Revenue Growth
+29.59%

Earnings Announcement Details

Quarter
Q4 2022
Date
02/23/2023
Time
Before Open
Conference Call
Thursday, February 23, 2023
GB:0HD2 Upcoming Earnings

Alnylam Pharma's next earnings date is estimated for February 18, 2027, based on past reporting schedules.

Q4 2022 Earnings Call Audio

GB:0HD2 Q4 2022 Earnings Call
0:00 / 0:00

Q4 2022 Earnings Slide Deck

No slide deck is available for this earnings event.

Q4 2022 Earnings Call Summary

No earnings call summary is available for this earnings event.

GB:0HD2 Earnings History

GB:0HD2 earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Feb 18, 20272026 (Q4)1.72-0.82――
Oct 29, 20262026 (Q3)1.6615.721.84754.35% (+13.88)
Jul 30, 20262026 (Q2)1.631.21-0.51337.25% (+1.72)
Apr 30, 20262026 (Q1)0.871.51-0.44443.18% (+1.95)
Feb 12, 20262025 (Q4)1.150.82-0.65226.15% (+1.47)
Oct 30, 20252025 (Q3)0.561.84-0.87311.49% (+2.71)
Jul 31, 20252025 (Q2)-0.54-0.51-0.13-292.31% (-0.38)
May 01, 20252025 (Q1)-0.89-0.44-0.5215.38% (+0.08)
Feb 13, 20252024 (Q4)-0.59-0.65-1.140.91% (+0.45)
Oct 31, 20242024 (Q3)-0.92-0.871.15-175.65% (-2.02)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed